Insulin-like growth factor II mRNA-binding protein 3: A novel prognostic biomarker for oral squamous cell carcinoma

Head and Neck

Volumn 33, Issue 3, 2011, Pages 368-374

  Li, Shengjin ^a   Cha, Jeongdan ^a   Kim, Jin ^a   Kim, Ki Yeol ^a   Kim, Hyung Jun ^a   Nam, Woong ^a   Cha, In Ho ^a  

^a Yonsei University College of Dentistry   (South Korea)

Author keywords

clinicopathologic factors; IMP3; oral squamous cell carcinoma; prognostic factor; survival

Indexed keywords

INSULIN LIKE GROWTH FACTOR II MRNA BINDING PROTEIN 3; MEMBRANE PROTEIN; ONCOPROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR II; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 79951712579     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21457     Document Type: Article

References (23)

1. Sudbo J, Reith A,. The evolution of predictive oncology and molecular-based therapy for oral cancer prevention. Int J Cancer 2005; 115: 339-345. (Pubitemid 40663735)
2. Lippman SM, Sudbo J, Hong WK,. Oral cancer prevention and the evolution of molecular-targeted drug development. J Clin Oncol 2005; 23: 346-356. (Pubitemid 46206883)
3. Pisani P, Parkin DM, Bray F, Ferlay J,. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29. (Pubitemid 29409471)
4. Myoung H, Kim MJ, Lee JH, Ok YJ, Paeng JY, Yun PY,. Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients. Int J Oral Maxillofac Surg 2006; 35: 1005-1010. (Pubitemid 44615441)
5. Epstein JB, Sciubba J, Silverman S Jr, Sroussi HY,. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice. Head Neck 2007; 29: 948-958.
6. Spafford MF, Koeppe J, Pan Z, Archer PG, Meyers AD, Franklin WA,. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1996; 122: 627-632. (Pubitemid 26178794)
7. Mueller-Pillasch F, Pohl B, Wilda M, et al. Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev 1999; 88: 95-99. (Pubitemid 29467415)
8. Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC,. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 1999; 19: 1262-1270. (Pubitemid 29046868)
9. Jiang Z, Chu PG, Woda BA, et al. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. Lancet Oncol 2006; 7: 556-564. (Pubitemid 43923666)
10. Mueller-Pillasch F, Lacher U, Wallrapp C, et al. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene 1997; 14: 2729-2733. (Pubitemid 27283112)
11. Li L, Xu H, Spaulding BO, et al. Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors. Hum Pathol 2008; 39: 1205-1211.
12. Jeng YM, Chang CC, Hu FC, et al. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Hepatology 2008; 48: 1118-1127.
13. Wang T, Fan L, Watanabe Y, et al. L523S, an RNA-binding protein as a potential therapeutic target for lung cancer. Br J Cancer 2003; 88: 887-894. (Pubitemid 36520876)
14. Xu H,. IMP3: a diagnostic and prognostic biomarker in malignant melanoma. Expert Rev Mol Diagn 2008; 8: 557-558.
15. Sitnikova L, Mendese G, Liu Q, et al. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder. Clin Cancer Res 2008; 14: 1701-1706. (Pubitemid 351469454)
16. Greene FL, Page DL, Fleming ID, et al. American Joint Committee on Cancer Staging Handbook: from the AJCC cancer staging manual. New York: Springer; 2002. pp 35-46.
17. Lee EJ, Kim J, Lee SA, et al. Characterization of newly established oral cancer cell lines derived from six squamous cell carcinoma and two mucoepidermoid carcinoma cells. Exp Mol Med 2005; 37: 379-390. (Pubitemid 41597251)
18. Chuang HC, Su CY, Huang HY, et al. Active matrix metalloproteinase-7 is associated with invasion in buccal squamous cell carcinoma. Mod Pathol 2008; 21: 1444-1450.
19. Zheng W, Yi X, Fadare O, et al. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma. Am J Surg Pathol 2008; 32: 304-315. (Pubitemid 351172146)
20. Hoffmann NE, Sheinin Y, Lohse CM, et al. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Cancer 2008; 112: 1471-1479. (Pubitemid 351441159)
21. Li C, Rock KL, Woda BA, Jiang Z, Fraire AE, Dresser K,. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression. Mod Pathol 2007; 20: 242-247. (Pubitemid 46422179)
22. Liao B, Hu Y, Herrick DJ, Brewer G,. The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells. J Biol Chem 2005; 280: 18517-18524. (Pubitemid 41389102)
23. Yaniv K, Fainsod A, Kalcheim C, Yisraeli JK,. The RNA-binding protein Vg1 RBP is required for cell migration during early neural development. Development 2003; 130: 5649-5661. (Pubitemid 37540841)